Form 990 for tax year 2024
Filed by NATIONAL ORGANIZATION FOR RARE DISORDERS INC.
Totals
- Total revenue
- $50,676,798
- Total expenses
- $43,034,462
- Contributions and grants received
- $40,390,497
- Grants paid
- $23,396,846
- Program service revenue
- $7,674,762
- Investment income
- $2,611,539
- Other revenue
- $0
- Total assets, end of year
- $72,321,740
- Total liabilities, end of year
- $3,745,803
- Net assets or fund balances, end of year
- $68,575,937
- Program services expenses (Part IX)
- $35,833,201
- Management and general expenses
- $4,036,856
- Fundraising expenses
- $3,164,405
- Program service expenses (Part III)
- $35,833,201
Program services were 83.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1b · Membership dues
$2,169,556
-
1e · Government grants (contributions)
$1,674,930
-
1f · All other contributions, gifts and grants
$36,546,011
-
2a · Program service revenue: PATIENT ASSISTANCE FEE
total $4,586,291 · related or exempt $4,586,291
-
2b · Program service revenue: PROGRAMMATIC EVENTS AN
total $1,743,097 · related or exempt $1,743,097
-
2c · Program service revenue: REGISTRY AND OTHER FEE
total $1,107,915 · related or exempt $1,107,915
-
2d · Program service revenue: DRUG, TRAVEL AND LODGI
total $126,426 · related or exempt $126,426
-
2e · Program service revenue: RESEARCH FEES
total $111,033 · related or exempt $111,033
-
3 · Investment income
total $2,489,178 · excluded $2,489,178
-
7a · Gross sales of assets other than inventory
securities $45,051,317
-
7b · Less cost or other basis and sales expenses
securities $44,928,956
-
7c · Gain or loss
securities $122,361
-
7d · Net gain or loss
total $122,361 · excluded $122,361
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $40,000 · program services $40,000
-
2 · Grants to domestic individuals
total $23,001,503 · program services $23,001,503
-
3 · Grants to foreign organizations and individuals
total $355,343 · program services $355,343
-
5 · Compensation of officers, directors and key employees
total $1,173,848 · program services $579,870 · management and general $323,176 · fundraising $270,802
-
7 · Other salaries and wages
total $8,873,978 · program services $5,380,666 · management and general $2,157,546 · fundraising $1,335,766
-
8 · Pension plan contributions
total $365,446 · program services $245,219 · management and general $81,973 · fundraising $38,254
-
9 · Other employee benefits
total $1,460,808 · program services $1,165,278 · management and general $37,431 · fundraising $258,099
-
10 · Payroll taxes
total $703,155 · program services $350,765 · management and general $258,020 · fundraising $94,370
-
11b · Fees: legal
total $245,408 · program services $82,170 · management and general $146,488 · fundraising $16,750
-
11c · Fees: accounting
total $59,500 · management and general $59,500
-
11d · Fees: lobbying
total $263,131 · program services $263,131
-
11f · Fees: investment management
total $23,889 · management and general $23,889
-
11g · Fees: other
total $2,097,075 · program services $1,412,479 · management and general $120,370 · fundraising $564,226
-
14 · Information technology
total $602,149 · program services $123,936 · management and general $416,372 · fundraising $61,841
-
16 · Occupancy
total $520,828 · program services $255,905 · management and general $212,962 · fundraising $51,961
-
17 · Travel
total $93,992 · program services $85,161 · management and general $4,713 · fundraising $4,118
-
19 · Conferences, conventions and meetings
total $1,702,825 · program services $1,401,071 · management and general $50,641 · fundraising $251,113
-
22 · Depreciation, depletion and amortization
total $917,962 · program services $779,913 · management and general $2,296 · fundraising $135,753
-
24a · Other expenses: MISCELLANEOUS
total $490,489 · program services $267,658 · management and general $141,479 · fundraising $81,352
-
24b · Other expenses: RESEARCH GRANT EXPENSE
total $43,133 · program services $43,133
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $4,078,715 · end of year $4,343,127
-
2 · Savings and temporary cash investments
beginning of year $4,021,694 · end of year $8,924,597
-
4 · Accounts receivable
beginning of year $20,885,685 · end of year $11,405,783
-
9 · Prepaid expenses and deferred charges
beginning of year $371,112 · end of year $371,002
-
10a · Land, buildings and equipment: cost or other basis
$7,094,185
-
10b · Land, buildings and equipment: accumulated depreciation
$5,025,203
-
10c · Land, buildings and equipment, net
beginning of year $1,909,847 · end of year $2,068,982
-
11 · Investments: publicly traded securities
beginning of year $33,249,776 · end of year $44,477,084
-
14 · Intangible assets
beginning of year $108,039 · end of year $102,597
-
15 · Other assets
beginning of year $529,596 · end of year $628,568
-
17 · Accounts payable and accrued expenses
beginning of year $2,676,954 · end of year $1,716,009
-
18 · Grants payable
beginning of year $672,379 · end of year $675,513
-
19 · Deferred revenue
beginning of year $513,639 · end of year $527,082
-
25 · Other liabilities
beginning of year $670,049 · end of year $827,199
-
27 · Net assets without donor restrictions
beginning of year $11,194,506 · end of year $10,013,533
-
28 · Net assets with donor restrictions
beginning of year $49,426,937 · end of year $58,562,404
Mission and programs · 2024
Mission
NORD STRIVES TO IMPROVE THE HEALTH AND WELL-BEING OF PEOPLE WITH RARE DISEASES BY DRIVING ADVANCES IN CARE, RESEARCH, AND POLICY.
-
NORD PATIENT ASSISTANCE PROGRAMS PROVIDE ELIGIBLE INDIVIDUALS WITH THE FINANCIAL ASSISTANCE FOR THE GREATEST BREADTH OF CARE AND TREATMENT NEEDS TO MANAGE THEIR RARE DIAGNOSES. OUR DISEASE-STATE SPECIFIC PROGRAMS TAKE INTO CONSIDERATION THE NUANCES OF INDIVIDUAL DISEASE AND THE UNIQUE NEEDS OF THE PATIENT POPULATION. THIS INCLUDES ASSISTANCE WITH HEALTH INSURANCE PREMIUMS, COPAYMENTS, AND COINSURANCE AS WELL AS CERTAIN OUT-OF-POCKET EXPENSES. OUR APPROACH ENSURES THAT ELIGIBLE INDIVIDUALS WHO HAVE HEALTH INSURANCE (COMMERCIAL AND/OR PUBLIC INSURANCE), AS WELL AS INDIVIDUALS WHO ARE UNINSURED OR UNDERINSURED, RECEIVE THE FINANCIAL ASSISTANCE NECESSARY TO ACCESS THE CARE AND TREATMENT PRESCRIBED BY THEIR HEALTH CARE PROVIDER(S). IN 2024, NORD PATIENT ASSISTANCE PROGRAMS PROVIDED FINANCIAL ASSISTANCE TO A TOTAL OF 6,268 INDIVIDUALS. THIS INCLUDED 6,024 ASSISTED THROUGH OUR PAP PROGRAMS AND CLINICAL TRIAL TRAVEL AND LODGING SUPPORT FOR 244 INDIVIDUALS IN 2024.
Expenses $27,777,318 · Grants $23,396,846 · Revenue $4,712,716
-
NORD'S EDUCATIONAL INITIATIVES STRIVE TO EMPOWER PATIENTS AND THEIR FAMILIES, INFORM AND EDUCATE STUDENTS ACROSS DISCIPLINES FROM HIGH SCHOOL THROUGH GRADUATE SCHOOL, AND SUPPORT THE VITALLY IMPORTANT WORK OF PHYSICIANS AND OTHER HEALTHCARE PROFESSIONALS IN IMPROVING THE RECOGNITION OF SYMPTOMS OF RARE DISEASE AND EARLY, ACCURATE DIAGNOSIS AS WELL AS IMPROVING CLINICIAN KNOWLEDGE AND COMPETENCE IN TREATING RARE DISEASES. THIS IS DONE THROUGH THE DEVELOPMENT OF NORD'S RARE DISEASE DATABASE, THE DELIVERY OF RARE DISEASE VIDEOS AND WEBINARS, AND THROUGH ROBUST EDUCATIONAL PROGRAMMING WITH NORD'S CME PROGRAM AND AT THE LIVING RARE, LIVING STRONGER NORD PATIENT AND FAMILY FORUM AND THE NORD RARE DISEASES AND ORPHAN PRODUCTS SUMMIT. IN 2024, 794 PEOPLE ATTENDED THE NORD SUMMIT IN PERSON, AND 64 PEOPLE REGISTERED FOR VIRTUAL STREAMING OF THE MEETING. ALSO, IN 2024, THERE WERE OVER 15 MILLION VISITORS TO NORD'S RARE DISEASE DATABASE.
Expenses $2,106,223 · Revenue $2,017,947
-
IN 2024, NORD CONTINUED TO DEVELOP THE IAMRARE NATURAL HISTORY/REGISTRY PLATFORM AND PROGRAM TO HELP RESEARCHERS BETTER UNDERSTAND THE PATIENT EXPERIENCE AND PROMOTE THE DEVELOPMENT OF INNOVATIVE, SAFE, AND EFFECTIVE THERAPIES. NEW IAMRARE PLATFORM FEATURES ADDED THIS YEAR INCLUDED ENHANCEMENTS TO THE USER EXPERIENCE AND SUPPORT FOR ADDITIONAL LANGUAGES (SPANISH AND FRENCH). AS OF 12-31-2024, THERE WERE 17,591 CONSENTED PARTICIPANTS ACROSS 44 REGISTRIES REPRESENTING MORE THAN 140 RARE DISEASES. IN ADDITION, AS OF 12-31-2024, THE RESEARCH TEAM WAS SUPPORTING THE DEVELOPMENT OF 30 NEW RARE DISEASE REGISTRIES.
Expenses $3,280,664 · Revenue $944,099
-
NORD'S ADVOCACY EFFORTS ARE FOCUSED ON SERVING AS A LIAISON BETWEEN THE RARE DISEASE COMMUNITY AND THE VARIOUS ORGANIZATIONS AND INSTITUTIONS THAT HAVE A DIRECT IMPACT ON THE LIVES OF THE 30 MILLION AMERICANS LIVING WITH RARE DISEASES. NORD ENGAGES ALL TYPES OF ORGANZIATIONS, INCLUDING STATE AND FEDERAL AGENCIES AND LEGISLATORS, OTHER NON-PROFIT ORGANIZATIONS, AND FOR-PROFIT ORGANIZATIONS TO HELP RAISE AWARENESS AROUND THE NEEDS OF RARE DISEASE PATIENTS AND TO COLLECTIVELY CONTRIBUTE TO REALIZING SOLUTIONS THAT CAN POSITIVELY IMPACT THE DIVERSE RARE DISEASE COMMUNITY.
Expenses $1,220,481
-
AS THE LEADING RARE DISEASE UMBRELLA ORGANIZATION IN THE UNITED STATES, THE NATIONAL ORGANIZATION FOR RARE DISORDERS PROVIDES ITS MEMBER ORGANIZATIONS WITH COMPREHENSIVE SUPPORT IN ADVOCACY, EDUCATION, RESEARCH, PROFESSIONAL DEVELOPMENT, ORGANIZATIONAL LEADERSHIP, AND COMMUNICATIONS. THROUGH OUR PROGRAMS AND SERVICES, WE EQUIP ORGANIZATIONAL LEADERS AND MEMBERS WITH THE ESSENTIAL TOOLS AND RESOURCES NEEDED TO STAY INFORMED, CONNECTED, AND EMPOWERED AS THEY ESTABLISH, GROW, AND STRENGTHEN THEIR ORGANIZATIONS. AS OF DECEMBER 2024, NORD PROUDLY SUPPORTED 356 MEMBER PATIENT ORGANIZATIONS.
Expenses $379,805
-
THE NORD RARE DISEASE CENTERS OF EXCELLENCE PROGRAM WAS ESTABLISHED TO SELECT AND TO COLLABORATE WITH A NETWORK OF US MEDICAL INSTITUTIONS WITH EXCEPTIONAL CLINICAL AND RESEARCH PROGRAMS FOR PATIENTS WITH RARE DISEASES, WHO WILL WORK COLLABORATIVELY WITH NORD, WITH ONE ANOTHER, AND WITH THEIR LOCAL COMMUNITIES OF PHYSICIANS, CAREGIVERS, AND PATIENTS TO SHARE EXPERT KNOWLEDGE, DEFINE STANDARDS OF PRACTICE FOR RARE DISEASES, ACCELERATE DIAGNOSIS, AND IMPROVE PATIENT CARE, TREATMENT, AND RESEARCH IN RARE DISEASES. AS OF DECEMBER 2024, THERE WERE 40 DESIGNATED NORD RARE DISEASE CENTERS OF EXCELLENCE.
Expenses $1,068,710
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Peter SaltonstallPETER SALTONSTALL
CEO (UNTIL 5/24)/CEO EMERITUS (AS OF 5/24)
- Total calculated
- $398,956
- From this org
- $374,441
- From related orgs
- $0
- Other
- $24,515
- Hours/week
- 35
Schedule J breakdown matched by us
- Base
- $349,441
- Bonus
- $25,000
- Other
- $0
- Deferred
- $17,250
- Nontaxable benefits
- $7,265
- Filer's total
- $398,956
-
Kathleen HolcombeKATHLEEN HOLCOMBE
CHAIR
- Total calculated
- $0
- Hours/week
- 10
-
Sheldon Schuster PhDSHELDON SCHUSTER PHD
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
Leon EidelmanLEON EIDELMAN
TREASURER (UNTIL 12/24)
- Total calculated
- $0
- Hours/week
- 5
-
Jim PalmaJIM PALMA
SECRETARY
- Total calculated
- $0
- Hours/week
- 5
-
Dennis JackmanDENNIS JACKMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Mark SkinnerMARK SKINNER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Susan Berry MDSUSAN BERRY MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Shafali Jeste MDSHAFALI JESTE MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Phillip Pearl MDPHILLIP PEARL MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Mike PorathMIKE PORATH
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Tom KellyTOM KELLY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Lorna WeirLORNA WEIR
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Pamela GavinPAMELA GAVIN
EVP (UNTIL 5/24)/CEO (AS OF 5/24)
- Total calculated
- $475,492
- From this org
- $441,759
- From related orgs
- $0
- Other
- $33,733
- Hours/week
- 35
Schedule J breakdown matched by us
- Base
- $416,759
- Bonus
- $25,000
- Other
- $0
- Deferred
- $17,250
- Nontaxable benefits
- $16,483
- Filer's total
- $475,492
-
Neeta KotechaNEETA KOTECHA
VP & CFO
- Total calculated
- $221,966
- From this org
- $179,637
- From related orgs
- $0
- Other
- $42,329
- Hours/week
- 35
Schedule J breakdown matched by us
- Base
- $179,637
- Bonus
- $0
- Other
- $0
- Deferred
- $9,373
- Nontaxable benefits
- $32,956
- Filer's total
- $221,966
-
Kelleen EsperiasKELLEEN ESPERIAS
CHIEF STRATEGY & OPERATIONS OFFICER
- Total calculated
- $77,435
- From this org
- $71,108
- From related orgs
- $0
- Other
- $6,327
- Hours/week
- 35
-
Edward NeilanEDWARD NEILAN
CHIEF MEDICAL & SCIENTIFIC OFFICER
- Total calculated
- $332,277
- From this org
- $270,662
- From related orgs
- $0
- Other
- $61,615
- Hours/week
- 35
Schedule J breakdown matched by us
- Base
- $270,662
- Bonus
- $0
- Other
- $0
- Deferred
- $14,420
- Nontaxable benefits
- $47,195
- Filer's total
- $332,277
-
Prashant GoelPRASHANT GOEL
VP INFORMATION TECHNOLOGY
- Total calculated
- $298,064
- From this org
- $283,442
- From related orgs
- $0
- Other
- $14,622
- Hours/week
- 35
Schedule J breakdown matched by us
- Base
- $283,442
- Bonus
- $0
- Other
- $0
- Deferred
- $14,205
- Nontaxable benefits
- $417
- Filer's total
- $298,064
-
Patrick CollinsPATRICK COLLINS
VP COMMUNITY & CORPORATE AFFAIRS
- Total calculated
- $265,586
- From this org
- $207,141
- From related orgs
- $0
- Other
- $58,445
- Hours/week
- 35
Schedule J breakdown matched by us
- Base
- $207,141
- Bonus
- $0
- Other
- $0
- Deferred
- $11,250
- Nontaxable benefits
- $47,195
- Filer's total
- $265,586
-
Alexandra MooreALEXANDRA MOORE
VP OF DEVELOPMENT
- Total calculated
- $258,059
- From this org
- $245,775
- From related orgs
- $0
- Other
- $12,284
- Hours/week
- 35
Schedule J breakdown matched by us
- Base
- $225,775
- Bonus
- $20,000
- Other
- $0
- Deferred
- $12,284
- Nontaxable benefits
- $0
- Filer's total
- $258,059
-
Jill PollanderJILL POLLANDER
VP PATIENT SERVICES
- Total calculated
- $208,148
- From this org
- $182,382
- From related orgs
- $0
- Other
- $25,766
- Hours/week
- 35
Schedule J breakdown matched by us
- Base
- $182,382
- Bonus
- $0
- Other
- $0
- Deferred
- $9,283
- Nontaxable benefits
- $16,483
- Filer's total
- $208,148
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- PART I, LINE 7
- THE BOARD OF DIRECTORS REVIEWS EXTERNAL SURVEYS, DOL, BLS, AND ACCOUNTEMP SURVEYS FOR DECISIONS ON THE EXECUTIVE DIRECTOR'S COMPENSATION. THERE IS ALSO A SALARY ADMINISTRATION PLAN THAT TAKES INTO CONSIDERATION GEOGRAPHIC SETTINGS, SKILLS, AND EDUCATION.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$25,000
FINAL PAYMENT FOR ACPMP RESEARCH GRANT NORD ID 15005
-
FIRST PAYMENT OF 2 FOR MMIHS RESEARCH
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $355,343
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | GRANTS TO RECIPIENTS | — | $6,830 |
| NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 0 | 0 | GRANTS TO RECIPIENTS | — | $82,681 |
| SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | 0 | 0 | GRANTS TO RECIPIENTS | — | $258,316 |
| EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, | 0 | 0 | GRANTS TO RECIPIENTS | — | $7,516 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | $257,316 | BANK OF AMERICA INTERNATIONAL WIRE | $0 | — | BOOK |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- 1
- Other grantees (Part II line 3)
- 6
Grants to individuals, by region (Part III)
The type of assistance is not shown.
| Region | Recipients | Cash grants | Manner of disbursement | Noncash assistance |
|---|---|---|---|---|
| NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 1 | $75,888 | WIRE | — |
| NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 4 | $2,751 | WIRE | — |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU | 2 | $759 | WIRE | — |
| EAST ASIA AND THE PACIFIC | 6 | $7,516 | WIRE | — |
| EAST ASIA AND THE PACIFIC | 2 | $1,000 | WIRE | — |
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 6 June 2025
- IRS schema version
- 2024v5.1
- Source object
- 202521609349300767
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.